eMolecules, a chemical compound search-and-fulfillment platform for early discovery chemistry research, has announced the acquisition of Specs Compound Handling B.V…. Continue Reading
Articles
Medtronic to Acquire Wearable Insulin Patch Maker EOFlow
Medtronic, a global leader in healthcare technology, has announced its plans to acquire EOFlow, the manufacturer of the EOPatch device,… Continue Reading
UNC Health to Pilot Epic, Microsoft’s Generative AI Tool
UNC Health is set to become one of the early adopters of Generative AI (Artificial Intelligence) tools through a program… Continue Reading
Florence Acquires Telehealth Platform Zipnosis from Bright Health
Healthcare enablement software company Florence has acquired Zipnosis, an asynchronous-first virtual care solution, in an undisclosed all-cash deal. The acquisition… Continue Reading
Pyxis Oncology to Acquire Apexigen
Pyxis Oncology has announced its acquisition of Apexigen in an all-stock transaction valued at approximately $16 million. The acquisition will… Continue Reading
Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy
Ironwood Pharmaceuticals has announced its acquisition of VectivBio in a cash deal worth approximately $1 billion. The acquisition will expand… Continue Reading
Florence Acquires Virtual Care Solution Zipnosis
Healthcare enablement software company Florence has announced its acquisition of Zipnosis, a virtual care solution focused on asynchronous telemedicine. This… Continue Reading
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq-Listed Company
Theralink Technologies and IMAC Holdings have signed a definitive Agreement and Plan of Merger for a stock-for-stock reverse merger. The… Continue Reading
ReNAgade Launches with $300M to More Easily Deliver RNA Medicines
ReNAgade Therapeutics, a Massachusetts-based start-up, has launched with $300 million in Series A financing to develop RNA medicines for previously… Continue Reading
TScan Therapeutics Announces Pricing of $140 Million Public Offering
TScan Therapeutics, a biopharmaceutical company specializing in T cell receptor-engineered T cell therapies for cancer treatment, has priced an underwritten… Continue Reading